Patent office backlog adds billions to national drug expenditure
Authors:
- 8 May 2014
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 32 (5) , 436-439
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Evergreening, patent challenges, and effective market life in pharmaceuticalsJournal of Health Economics, 2012
- When Do Generics Challenge Drug Patents?Journal of Empirical Legal Studies, 2011
- Evergreening: a common practice to protect new drugsNature Biotechnology, 2011
- Prescription drug accessibility and affordability in the United States and abroad.2010